NXF1

Nuclear RNA export factor 1 · Q9UBU9 · NXF1 on Sugi Atlas →

0 patent compounds predicted against NXF1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NXF1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Ivermectin and Nitazoxanide Combination Therapy for COVID-19 PHASE2/PHASE3UNKNOWN
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma PHASE2RECRUITING
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma PHASE1/PHASE2RECRUITING
Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. PHASE1/PHASE2RECRUITING
A Trial of Selinexor, Ruxolitinib and Methylprednisolone PHASE1RECRUITING
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA) nanRECRUITING
Biomarkers of Cancer-Associated Myositis nanACTIVE_NOT_RECRUITING
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections nanCOMPLETED
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) nanRECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa nanCOMPLETED
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
Inflammation in HIV/AIDS-InflammAIDS nanCOMPLETED
Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction nanCOMPLETED
Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C nanRECRUITING
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPITRAN) nanUNKNOWN
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION

Related proteins — ESM-2 sequence neighbours (a NXF1 binder may also engage these)

ProteinNameSimilarity
Q1RMS5 1.000 Q1RMS5 →
Q5R752 1.000 Q5R752 →
O88984 0.995 O88984 →
Q99JX7 0.989 Q99JX7 →
P58797 0.987 P58797 →
O60879 0.956 O60879 →
F1QH17 0.951 F1QH17 →
B6CZ45 0.950 B6CZ45 →
PARN Poly(A)-specific ribonuclease PARN 0.949 landscape →
Q63787 0.947 Q63787 →
P26450 0.947 P26450 →
PIK3R1 Phosphatidylinositol 3-kinase regulatory subunit alpha 0.947 landscape →
DCUN1D5 DCN1-like protein 5 0.947 landscape →
Q5RC51 0.946 Q5RC51 →
Q2HJF8 0.946 Q2HJF8 →
Q63789 0.946 Q63789 →
B6CZ40 0.945 B6CZ40 →
B6CZ54 0.945 B6CZ54 →
P69341 0.945 P69341 →
Q5EAD8 0.945 Q5EAD8 →
Q96E66 0.945 Q96E66 →
Q95JI3 0.944 Q95JI3 →
Q9NZI6 0.944 Q9NZI6 →
P23727 0.944 P23727 →
Q08DP6 0.944 Q08DP6 →
Q9DAF3 0.944 Q9DAF3 →
P17426 0.943 P17426 →
Q9H0P0 0.943 Q9H0P0 →
Q7ZWU5 0.943 Q7ZWU5 →
Q9D020 0.943 Q9D020 →